Search Results - "McNaught, Kevin St.P."
-
1
Proteasomal function is impaired in substantia nigra in Parkinson's disease
Published in Neuroscience letters (19-01-2001)“…The accumulation of α-synuclein, ubiquitin and other proteins in Lewy bodies in degenerating dopaminergic neurones in substantia nigra in idiopathic…”
Get full text
Journal Article -
2
Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation
Published in Biochemical pharmacology (01-10-2000)“…Dopaminergic neuronal death in substantia nigra in Parkinson’s disease is accompanied by depletion of reduced glutathione levels and inhibition of complex I…”
Get full text
Journal Article -
3
Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Published in Neuroscience letters (08-03-1996)“…Isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or 1-methyl-4-phenylpyridinium (MPP +) are inhibitors of…”
Get full text
Journal Article -
4
Selective loss of 20S proteasome α-subunits in the substantia nigra pars compacta in Parkinson's disease
Published in Neuroscience letters (05-07-2002)“…The proteolytic activities of 26/20S proteasomes are impaired in the substantia nigra pars compacta (SNc) in sporadic Parkinson's disease (PD). In the present…”
Get full text
Journal Article -
5
The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease
Published in Synapse (New York, N.Y.) (01-03-2010)“…The basis of neuronal vulnerability, degeneration, and sparing in PD are unknown, but there is increasing evidence to suggest that the ubiquitin‐proteasome…”
Get full text
Journal Article -
6
Proteolytic dysfunction in neurodegenerative disorders
Published in International review of neurobiology (2004)Get more information
Journal Article -
7
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson’s disease
Published in Biochemical pharmacology (15-10-1998)“…The cause of neurodegeneration in Parkinson’s disease (PD) remains unknown. However, isoquinoline derivatives structurally related to the selective…”
Get full text
Journal Article -
8
Dysfunction of rat forebrain astrocytes in culture alters cytokine and neurotrophic factor release
Published in Neuroscience letters (05-05-2000)“…Altered glial cell function occurring in substantia nigra in Parkinson’ disease may lead to the release of cytokines and impairment of neurotrophic factor…”
Get full text
Journal Article -
9
Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)
Published in Biochemical pharmacology (27-11-1995)“…Mitochondrial respiratory failure secondary to complex I inhibition may contribute to the neurode-generative process underlying nigral cell death in…”
Get full text
Journal Article -
10
Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration
Published in Biochemical pharmacology (14-06-1996)“…Isoquinoline derivatives exert 1-methyl-4-phenylpyridinium (MPP +)-like activity as inhibitors of complex I and α-ketoglutarate dehydrogenase activity in rat…”
Get full text
Journal Article -
11
Nitric oxide causes release of glutamate from brain synaptosomes
Published in Biochemical Society transactions (01-08-1997)Get more information
Journal Article -
12
Inhibition of [ 3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Published in Biochemical pharmacology (12-07-1996)“…Isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or 1-methyl-4-phenylpyridinium (MPP +) may be endogenous…”
Get full text
Journal Article -
13
Inhibition of alpha-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Published in Neuroreport (30-05-1995)“…Defects in complex I and alpha-ketoglutarate dehydrogenase (alpha-KGDH) occur in the substantia nigra in Parkinson's disease (PD). Isoquinoline derivatives…”
Get more information
Journal Article -
14
Nigral Cell Loss Produced by Infusion of Isoquinoline Derivatives Structurally Related to 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine
Published in Neurodegeneration (London, England) (01-09-1996)“…Isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6Ndash;tetrahydropyridine or 1-methyl-4-phenylpyridinium (MPP +) are potential…”
Get full text
Journal Article